SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hargarten Christina

(Last)

(First)

(Middle)

C/O RH

15 KOCH ROAD, SUITE K

(Street)

CORTE MADERA

94925

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2021

3. Issuer Name and Ticker or Trading Symbol
RH [ RH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	04/01/2029	Common Stock	3,750	101.25	D
Stock Option (Right to Buy)	⁽²⁾	04/28/2030	Common Stock	2,700	154.82	D

Explanation of Responses:

1. This option award will vest and become exercisable with respect to 750 shares on April 2, 2022, an additional 1,000 shares on April 2, 2023 and an additional 2,000 shares on April 2, 2024, subject to continuous service.

2. This option award will vest and become exercisable with respect to 300 shares on April 29, 2022, an additional 300 shares on April 29, 2023, an additional 450 shares on April 29, 2024, an additional 450 shares on April 29, 2025, an additional 600 shares on April 29, 2026, and an additional 600 shares on April 29, 2027, subject to continuous service.

Remarks:

Interim Chief Accounting Officer and Principal Accounting Officer

	/s/ Edward T. Lee, Attorney-in-Fact	09/10/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.